Deal Announced for New Multi-Room Proton Therapy Center in China

By MedImaging International staff writers
Posted on 11 Jul 2016
A contract worth more than EUR 80 million has been signed for the installation of a new multi-room proton therapy center in a new cancer treatment center in Qingdao, Shandong Province, China.

The deal includes a fixed-beam treatment room, four isocentric-gantry treatment rooms, and a long-term operations and maintenance contract. The company will also provide all required dosimetry equipment for the center, which should be ready to treat patients by the end of 2018. The deal will also include adaptive intensity modulated proton-therapy pencil-beam scanning and Cone Beam Computer Tomography (CBCT).

Image: The ProteusPLUS proton therapy solution (Photo courtesy of IBA Proton Therapy).

The contract was awarded to IBA Proton Therapy (Louvain-La-Neuve, Belgium) by the Qingdao Zhong Jia Lian He healthcare management company (Qingdao, Shandong Province, China).

Wang Xiang Yu, of the Qingdao Zhong Jia Lian He company, said, “We want to have the most innovative treatments for our cancer patients in order to effectively fight this severe disease; proton therapy will help give our team of oncologists the critical tools to fight cancer. Our new ProteusPLUS multi-room solution, including Pencil Beam Scanning and Cone Beam CT technology, will be installed by IBA and will allow us to ‘paint’ tumors with a super-fine beam of protons, destroying cancer cells whilst leaving surrounding healthy tissue untouched.”

Related Links:
IBA Proton Therapy


Latest Industry News News